Press "Enter" to skip to content

Metabolomics Market Size 2019 – Growing Demand Status of Top Manufacturers with Industry Share, Size, Projection, Consumption Forecast to 2024

Metabolomics

The “Metabolomics Market” report 2019 provides information for market players, stakeholders, investors, and business strategists to achieve a leading position the market. It maintains the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Metabolomics market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Metabolomics market is provided in detail in the report.

Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14099119  

Metabolomics Market Covers Key Players:

  • Agilent Technologies
  • Bio
  • Rad Laboratories Inc.
  • Bruker Corporation
  • Danaher Corporation (SCIEX)
  • LECO Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific
  • Waters Corporation
  • PerkinElmer Inc.
  • Kore Technology Limited

    Market Overview:

  • The metabolomics market was valued at USD 1,637.43 million in 2018, and is expected to reach USD 3,565.82 million by 2024. It is estimated to register a CAGR of 13.85%, during the forecast period (2019-2024).
  • The high growth rate for this market is primarily due to its high demand in scientific communities for better analysis of diseases, biological processes, and growing applications in healthcare. There are a growing number of research universities collaborating with companies in developed markets, which use a combination of separation and detection techniques, such as GC-MS, for metabolite profiling of large sets of drugs for diagnosis and treatment of several chronic diseases, like diabetes mellitus. These researches are often recognized at the national level, and governments with private equity partners provide funds for more research toward drug discovery, biomarkers, and other related studies.

    Report Highlights:

    • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    • Market forecasts till 2024, using estimated market values as the base numbers
    • Key market trends across the business segments, Regions and Countries
    • Key developments and strategies observed in the market
    • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    • In-depth company profiles of key players and upcoming prominent players
    • Growth prospects among the emerging nations through 2024
    • Metabolomics Market opportunities and recommendations for new investments

    For More Information or Query or Customization Before Buying, Visit athttps://www.industryresearch.co/enquiry/pre-order-enquiry/14099119

    Scope of the Report:

  • Metabolomics represent a systematic study of unique chemical processes inside the cells, which involve metabolites. The collection of entire metabolites in a biological cell, tissue, organ, or organism is called metabolome, which are the end products of cellular processes. In the past one decade, the scientific communities across the world have been integrating proteomic, transcriptomic, and metabolomic information, which helps in the early analysis of any chronic genetic or infectious diseases. These are funded by several private and public funding, which helps in the growth of the metabolomics market.

    Key Market Trends:

    Biomarker and Drug Discovery Segment, under Application, is Expected to Hold the Highest Revenue

    The biomarket and drug discovery segment, under application, is projected to record a CAGR of 13.4%, over the forecast period.

    Metabolomics focus mainly on profiling small-molecule metabolites (metabolic profiling), and differ from genomics and proteomics, which characterize the profiles of genes and proteins, respectively. Additionally, biomarkers are the objective and quantitatively-measurable indicators of biological or pathogenic processes. Both metabolomics and biomarkers are progressively used in drug discovery and development, managing disease progression, especially for the personalized or precision medicine. Metabolomics and biomarkers are likely to advance the drug development and personalized therapy in the future, mainly in highly demanding disease areas, such as cardiovascular and metabolic diseases, cancer, mental health, and other infectious diseases. The increasing challenges faced by the pharmaceutical industry, such as dwindling discovery pipelines, limited budget sanctioned for a particular R&D, increasing regulatory control, significant gaps in the future drug markets, are expected to drive growth of the market.

    North America Dominates the Market and is Expected to do Same during the Forecast Period

    North America is expected to dominate the market, over other regions, throughout the forecast period. The presence of high per capita healthcare expenditure, increasing adoption rate of healthcare technology, well-established direct sales channel across the region, and continuous boost to small and mid-sized metabolomics-oriented research communities and companies, globally, from the National Institutes of Health (NIH) program, help in the growth of metabolomics business.

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14099119

    Detailed TOC of Metabolomics Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Demand for Personalized Medicines
    4.2.2 High Investments by Public and Private Sectors in the Field of Metabolomics
    4.2.3 Rising Need for Early and Accurate Diagnosis of Diseases
    4.3 Market Restraints
    4.3.1 High Cost of Tools and Instruments
    4.3.2 Lack of Skilled Professionals
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Metabolite Analysis
    5.1.1 Analytical Techniques
    5.1.1.1 Separation Techniques
    5.1.1.1.1 Liquid Chromatography
    5.1.1.1.2 Gas Chromatography
    5.1.1.1.3 Capillary Electrophoresis
    5.1.1.2 Detection Techniques
    5.1.1.2.1 Mass Spectrometry
    5.1.1.2.2 Nuclear Magnetic Resonance Spectroscopy
    5.1.1.2.3 Other Detection Techniques
    5.1.2 Bioinformatics Tools and Database
    5.2 By Application
    5.2.1 Biomarker and Drug Discovery
    5.2.2 Toxicology
    5.2.3 Nutrigenomics
    5.2.4 Personalized Medicine
    5.2.5 Other Applications
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 United Kingdom
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Agilent Technologies
    6.1.2 Bio-Rad Laboratories Inc.
    6.1.3 Bruker Corporation
    6.1.4 Danaher Corporation (SCIEX)
    6.1.5 LECO Corporation
    6.1.6 Shimadzu Corporation
    6.1.7 Thermo Fisher Scientific
    6.1.8 Waters Corporation
    6.1.9 PerkinElmer Inc.
    6.1.10 Kore Technology Limited

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Global Serum Market Share, Size 2019 – Industry Future Demand, Worldwide Research, Top Leading Players, Emerging Trends, Region by Forecast to 2024

    Global Perchloric Acid Market Share, Size 2019 Movements by Development Analysis, Progression Status, Revenue Expectation to 2026 | Research Report by Industry Research Biz

    Level Sensors Market 2019 to 2025 Structure with Top down & Bottom up Approach, Technological Trends – Global Forecast Report

    Flooring and Carpet Market 2019-2025 | Pointing to Capture Largest Market Growth and Share with Developed Economies – Industry Research.co

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *